Skip to main content
NCBI home page
The British Journal of General Practice logoLink to The British Journal of General Practice
letter
. 1998 Feb;48(427):1005–1006.

Prostate specific antigen in urinary tract infection.

C R Bell, S Natale, P D McInerney, J C Hammonds
PMCID: PMC1409989  PMID: 9624778

Full text

PDF
1005

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bissada N. K., Rountree G. A., Sulieman J. S. Factors affecting accuracy and morbidity in transrectal biopsy of the prostate. Surg Gynecol Obstet. 1977 Dec;145(6):869–872. [PubMed] [Google Scholar]
  2. Catalona W. J., Richie J. P., Ahmann F. R., Hudson M. A., Scardino P. T., Flanigan R. C., deKernion J. B., Ratliff T. L., Kavoussi L. R., Dalkin B. L. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol. 1994 May;151(5):1283–1290. doi: 10.1016/s0022-5347(17)35233-3. [DOI] [PubMed] [Google Scholar]
  3. Catalona W. J., Smith D. S., Ratliff T. L., Basler J. W. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA. 1993 Aug 25;270(8):948–954. [PubMed] [Google Scholar]
  4. Cooner W. H., Mosley B. R., Rutherford C. L., Jr, Beard J. H., Pond H. S., Terry W. J., Igel T. C., Kidd D. D. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol. 1990 Jun;143(6):1146–1154. doi: 10.1016/s0022-5347(17)40211-4. [DOI] [PubMed] [Google Scholar]
  5. Ercole C. J., Lange P. H., Mathisen M., Chiou R. K., Reddy P. K., Vessella R. L. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. J Urol. 1987 Nov;138(5):1181–1184. doi: 10.1016/s0022-5347(17)43543-9. [DOI] [PubMed] [Google Scholar]
  6. Hasui Y., Marutsuka K., Asada Y., Ide H., Nishi S., Osada Y. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate. 1994 Aug;25(2):91–96. doi: 10.1002/pros.2990250206. [DOI] [PubMed] [Google Scholar]
  7. Nadler R. B., Humphrey P. A., Smith D. S., Catalona W. J., Ratliff T. L. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol. 1995 Aug;154(2 Pt 1):407–413. doi: 10.1097/00005392-199508000-00023. [DOI] [PubMed] [Google Scholar]
  8. Oesterling J. E., Chan D. W., Epstein J. I., Kimball A. W., Jr, Bruzek D. J., Rock R. C., Brendler C. B., Walsh P. C. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol. 1988 Apr;139(4):766–772. doi: 10.1016/s0022-5347(17)42630-9. [DOI] [PubMed] [Google Scholar]
  9. Oesterling J. E., Jacobsen S. J., Chute C. G., Guess H. A., Girman C. J., Panser L. A., Lieber M. M. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA. 1993 Aug 18;270(7):860–864. [PubMed] [Google Scholar]
  10. Oesterling J. E. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol. 1991 May;145(5):907–923. doi: 10.1016/s0022-5347(17)38491-4. [DOI] [PubMed] [Google Scholar]
  11. Stamey T. A., Yang N., Hay A. R., McNeal J. E., Freiha F. S., Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987 Oct 8;317(15):909–916. doi: 10.1056/NEJM198710083171501. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES